161 related articles for article (PubMed ID: 36092957)
1. The Predicting Role of Serum TSGF and sIL-2R for the Lymph Node Metastasis of Papillary Thyroid Carcinoma.
Xu X; Wang W; Sun T; Tian B; Du L; Jing J
Dis Markers; 2022; 2022():3730679. PubMed ID: 36092957
[TBL] [Abstract][Full Text] [Related]
2. The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma.
Xu X; Wang W; Tian B; Zhang X; Ji Y; Jing J
BMC Cancer; 2023 Nov; 23(1):1067. PubMed ID: 37932676
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
Mariotti S; Barbesino G; Caturegli P; MarinĂ² M; Manetti L; Fugazzola L; Pacini F; Pinchera A
J Endocrinol Invest; 1994 Dec; 17(11):861-7. PubMed ID: 7745234
[TBL] [Abstract][Full Text] [Related]
4. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum B7-H3 expression, ultrasound and clinical characteristics to predict the risk of cervical lymph node metastases in papillary thyroid carcinoma by nomogram.
Huang Y; Huang Z; Cai H; Zhuge L; Wang S; Yan D; Zhang X; An C; Niu L; Li Z
J Clin Lab Anal; 2023 Jan; 37(1):e24811. PubMed ID: 36525343
[TBL] [Abstract][Full Text] [Related]
6. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
7. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
8. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
10. A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.
Yang Z; Heng Y; Zhao Q; Cao Z; Tao L; Qiu W; Cai W
Front Endocrinol (Lausanne); 2021; 12():743900. PubMed ID: 34659126
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
[TBL] [Abstract][Full Text] [Related]
12. [High aldehyde dehydrogenase 1A1 (ALDH1A1) expression correlated with risk of lymph node metastasis in papillary thyroid carcinoma].
Yue C; Zhao X; Tian C; Jin Y; Liu H
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):490-4. PubMed ID: 26705040
[TBL] [Abstract][Full Text] [Related]
13. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma.
Feng Y; Min Y; Chen H; Xiang K; Wang X; Yin G
J Endocrinol Invest; 2021 Oct; 44(10):2203-2211. PubMed ID: 33586026
[TBL] [Abstract][Full Text] [Related]
14. Disparity expression of gammaH2AX in papillary thyroid cancer and nodular goiter.
Hu S; Zhang G; Xu J; Zhu X; Lu X; Jiang L; Wang Q; Hou X; Cao J; Ge M
Clin Lab; 2014; 60(12):2031-7. PubMed ID: 25651738
[TBL] [Abstract][Full Text] [Related]
15. [Risk factors of level â…¥ lymph node metastasis in cN0 papillary thyroid carcinoma].
Ma N; Li JR; Guo HG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(8):641-644. PubMed ID: 29871097
[No Abstract] [Full Text] [Related]
16. [Related factors analysis for lymph node metastasis in papillary thyroid carcinoma: a series of 2 073 patients].
Sun QH; Zhang L; Yang JB; Liu YW; Liang F; Shi H; Liu ZW; Chen G; Chen SG; Shang ZH; Hu SB; Dong YW; Li YL; Li XY
Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):592-598. PubMed ID: 28789509
[No Abstract] [Full Text] [Related]
17. Magnetic Resonance Imaging Characteristics of Papillary Thyroid Carcinoma for the Prediction of Cervical Central Compartment Lymph Node Metastasis.
Wang H; Liu K; Ren J; Liu W; Chen Y; Song B
J Comput Assist Tomogr; 2019; 43(6):963-969. PubMed ID: 31162232
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of skip lateral lymph node metastasis in papillary thyroid carcinoma.
Hou J; Zhang Y; Fan Y; Wu B
Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):493-498. PubMed ID: 32607832
[TBL] [Abstract][Full Text] [Related]
19. Lymph node metastasis in young and middle-aged papillary thyroid carcinoma patients: a SEER-based cohort study.
Liu Y; Wang Y; Zhao K; Li D; Chen Z; Jiang R; Wang X; He X
BMC Cancer; 2020 Mar; 20(1):181. PubMed ID: 32131769
[TBL] [Abstract][Full Text] [Related]
20. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
